Navigation Links
Former Assistant US Surgeon General Woodie Kessel, MD, MPH, Joins Academic Network LLC as Senior Scientific Advisor
Date:6/25/2008

With enhanced medical leadership, Academic Network expands its virtual medical affairs services for food, beverage, healthcare and pharmaceutical companies.

Portland, OR (PRWEB) June 24, 2008 -- Award-winning Academic Network LLC, a leading medical and health research and communications company, today announced that former Assistant US Surgeon General Woodie Kessel, MD, MPH, has joined the firm as Senior Scientific Advisor. Spurred on by a sales growth record of nearly 300%, Academic Network adds Dr. Kessel to its team of medical experts to enhance the company's medical & health consulting, medical advisory services, and virtual medical affairs department.

"Dr. Kessel is an internationally recognized physician and public servant whose prestigious career in medicine and healthcare bring a new level of expertise to our clients wanting the best counsel to develop new products, support health claims, improve patient recruitment and retention practices, educate consumers and meet regulatory agency requirements," said Kate McCarron, chief executive officer, Academic Network LLC. "We have worked with Woodie for years on the Shaping America's Youth initiative (www.shapingamericasyouth.org) and know that his understanding of 21st century healthcare and medical issues will benefit all of our clients whether they are developing new products or in need of scientific advice."

In addition to serving in the Office of the US Surgeon General, Dr. Kessel, a pediatrician who has been awarded numerous honors and medals of excellence in public service, has also served as both Medical Director and Senior Surgeon for the US Public Health Service Commissioned Corps among countless other medical leadership roles. Kessel, who is best known for his advocacy for the improv
'/>"/>

Source:PRWeb

Page: 1 2 3

Related medicine news :

1. In Smoke-Free Minnesota, Five Former Smokers Share Their Struggles With Fighting Addiction
2. Medtronic Spine, Formerly Kyphon Inc., to Pay U.S. $75 Million to Resolve Allegations Of Defrauding Medicare
3. Melissa Biggs, Fashion Designer and Former Baywatch Actress, Teams with CSL Behring to Raise Awareness of Alpha-1 Antitrypsin Deficiency, a Commonly Misdiagnosed Respiratory Disease
4. Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care
5. ExamForce Hires Former (ISC)2 Americas Leader to Head Corporate and Government Sales Efforts
6. Former Dallas Cowboy Honored as Parker College of Chiropractic Top 2008 Graduate
7. Former Bristol-Myers Squibb Senior Vice President Indicted for Lying to the Federal Government About Popular Blood-Thinning Drug
8. LodgeNet Appoints John E. Haire, Former Time Warner Executive, to Board of Directors
9. Former U.S. Senate Majority Leaders Baker, Daschle, Dole, and Mitchell Launch Unprecedented Health Care Effort
10. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Inverness Medical Innovations, Inc. Who Invested in the Inverness Medical Innovations, Inc. Employee Savings Plan
11. Law Offices of Howard G. Smith Announces Investigation on Behalf of Current and Former Employees of Merck & Co., Inc. Who Invested in the Merck & Co., Inc. Employee Savings and Security Plan
Post Your Comments:
*Name:
*Comment:
*Email:
Other Medicine News:Health News:Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers' Compensation and Leave Administration Services for Employers 2Health News:Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers' Compensation and Leave Administration Services for Employers 3Health News:Sedgwick CMS and UnitedHealth Group to Develop Integrated Disability, Medical, Workers' Compensation and Leave Administration Services for Employers 4Health News:New book presents comprehensive survey of research into the molecular basis of aging 2Health News:BBVA Chairman Francisco González announces the BBVA Frontiers of Knowledge Awards 2Health News:BBVA Chairman Francisco González announces the BBVA Frontiers of Knowledge Awards 3Health News:Fluoridated water for Queensland ... at last 2Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 2Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 3Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 4Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 5Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 6Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 7Health News:Nationwide Survey Reveals Differing Physician and Patient Perceptions Regarding Impact of Ulcerative Colitis on Patients' Lives 8
Breaking Medicine Technology:Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 2Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 3Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 4Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 5Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 6Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 7Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 8Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 9Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 10Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 11Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 12Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 13Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2010 14Heska Announces Extension of Credit Agreement With Wells Fargo 2Heska Announces Extension of Credit Agreement With Wells Fargo 3Prodigy AutoCode Now Available in 116 Harris Teeter Pharmacies 56299 1Prodigy AutoCode Now Available in 116 Harris Teeter Pharmacies 56299 2Onyx Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference 13865 1Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 1Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 2Stand Up for Health Care 21 A Labor Day Message From RWDSU President Stuart Appelbaum 56294 3
Other Medicine Technology:Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 2Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 3Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 4Interim Response and Safety Analyses Support Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma 5Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 2Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 3Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 4Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy 5